Whether he has had discussions with the MHRA on conducting an audit of clinical-needs justifications submitted under Regulation 167 of the Human Medicines Regulations 2012 for cannabis-based products for medicinal use.
Awaiting answer.
Every parliamentary written question tabled by Stuart Andrew this session, with the full answer and department. See how every department answers, or back to the MP page.
Showing 1–20 of 356 · this parliament
Whether he has had discussions with the MHRA on conducting an audit of clinical-needs justifications submitted under Regulation 167 of the Human Medicines Regulations 2012 for cannabis-based products for medicinal use.
Awaiting answer.
Whether the General Medical Council has requested data including named services and individual prescribers relating to cannabis-based products for medicinal use from (a) his Department, (b) NHS England and (c) NHS Business Services Authority.
Awaiting answer.
For each UK Foundation Programme reserve-list allocation round held in 2026, how many applicants were allocated a place in that round from (a) the total pool of non-prioritised applicants, (b) Queen Mary University of London Malta, (c) Newcastle University Medicine Malaysia and (d) the City St George’s, University of London medical programme delivered in Cyprus; and how many applicants in each category remained without an allocation after that round.
Awaiting answer.
Which body is responsible for pursuing the return of medical equipment loaned to patients where that equipment was supplied by (a) an NHS trust and (b) an integrated care board.
NHS England does not collect information on medical equipment loaned to National Health Service patients outside of NHS premises. NHS trusts, often in partnership with local councils and regional integrated community equipment services, loan a wide range ...
What estimate his Department has made of the cost to the NHS of replacing medical equipment loaned to patients that is (a) lost, (b) damaged beyond repair and (c) not returned.
NHS England does not collect information on medical equipment loaned to National Health Service patients outside of NHS premises. NHS trusts, often in partnership with local councils and regional integrated community equipment services, loan a wide range ...
Whether NHS England collects information from NHS bodies on medical equipment loaned to patients that is \(a) lost, (b) damaged beyond repair and (c) not returned.
NHS England does not collect information on medical equipment loaned to National Health Service patients outside of NHS premises. NHS trusts, often in partnership with local councils and regional integrated community equipment services, loan a wide range ...
What guidance NHS England provides to NHS bodies on the (a) recording, (b) tracking and (c) recovery of medical equipment loaned to patients for use outside NHS premises.
NHS England does not collect information on medical equipment loaned to National Health Service patients outside of NHS premises. NHS trusts, often in partnership with local councils and regional integrated community equipment services, loan a wide range ...
How many genomic tests have been completed through the NHS Genomic Medicine Service in each quarter since April 2023 for (a) cancer and (b) rare and inherited conditions.
Awaiting answer.
Whether NHS England routinely collects data on turnaround times for genomic tests delivered through the NHS Genomic Medicine Service.
Awaiting answer.
What assessment his Department has made of trends in genomic testing activity through the NHS Genomic Medicine Service since April 2023; and what steps he is taking to help support access to genomi
Awaiting answer.
What assessment his Department has made of the adequacy of (a) workforce capacity, (b) laboratory capacity and (c) digital infrastructure across Genomic Laboratory Hubs in the context of future dem
Genomic testing in the National Health Service in England is provided through the NHS Genomic Medicine Service (NHS GMS) and delivered by a national genomic testing network of seven NHS Genomic Laboratory Hubs (GLHs).To support future demand for genomic t...
What modelling his Department has undertaken of potential future demand for genomic testing to support delivery of commitments in the NHS 10 Year Plan and National Cancer Plan.
NHS England is responsible for commissioning the NHS Genomic Medicine Service (NHS GMS). Genomic testing in the National Health Service in England is provided through the NHS GMS and delivered by a national genomic testing network of seven NHS Genomic Lab...
What assessment his Department has made of the level of need for NHS health professionals to ask about children’s screen use and social media exposure during routine case histories; and whether gui
Awaiting answer.
Whether the Department collects data on the health impacts of children’s exposure to harmful online content; and what assessment has been made of how the effectiveness of interventions designed to
Awaiting answer.
What assessment his Department has made of the support required for children and young people affected by age-related online restrictions; whether additional mental health or support services will
It is important that children and adults can benefit from the opportunities that appropriate use of technology can offer to boost wellbeing; however, this must be balanced with safety and protection from risks to their mental health.The Department of Heal...
With reference to the draft Value Based Procurement guidance for Medical Technology, what role NHS Trust Finance Directors will have in value assessments of medical technology; whether that guidanc
The Value Based Procurement (VBP) guidance, published on 11 June 2026, applies to medical technology as defined by the Medical Device Regulations 2002. This includes consumables, implants, diagnostics, equipment and digital technologies. The Department wo...
What assessment his Department has made of the level of alignment between the draft Value Based Procurement guidance for Medical Technology and (a) NHS Trust financial requirements under the 2025-2
The Value Based Procurement (VBP) guidance, published on 11 June 2026, applies to medical technology as defined by the Medical Device Regulations 2002. This includes consumables, implants, diagnostics, equipment and digital technologies. The Department wo...
With reference to the draft Value Based Procurement guidance for Medical Technology, whether that guidance applies across different categories of MedTech, including consumables, implants, diagnosti
The Value Based Procurement (VBP) guidance, published on 11 June 2026, applies to medical technology as defined by the Medical Device Regulations 2002. This includes consumables, implants, diagnostics, equipment and digital technologies. The Department wo...
With reference to the draft Value Based Procurement guidance for Medical Technology, what assessment his Department has made of (a) the availability of comparable clinical outcomes data across MedT
The Value Based Procurement (VBP) guidance, published on 11 June 2026, applies to medical technology as defined by the Medical Device Regulations 2002. This includes consumables, implants, diagnostics, equipment and digital technologies. The Department wo...
With reference to the draft Value Based Procurement guidance for Medical Technology, (a) whether procurement assessments are expected to include comparison with the existing standard of care, (b) h
The Value Based Procurement (VBP) guidance, published on 11 June 2026, applies to medical technology as defined by the Medical Device Regulations 2002. This includes consumables, implants, diagnostics, equipment and digital technologies. The Department wo...